Cargando…

Left Ventricular Assist Device Support for Fabry Cardiomyopathy: A Case Series

Patients with restrictive cardiomyopathy due to Fabry disease are often deemed ineligible for left ventricular assist device (LVAD) support due to the risk of suction events with a small LV cavity. We describe the first case series of LVAD support for Fabry disease. LVAD therapy can improve survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omid Kiamanesh, M.D., Moayedi, Yasbanoo, Aleksova, Natasha, Posada, Juan Duero, Gershon, Ariel, Seidman, Michael A., Rao, Vivek, Billia, Filio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893197/ https://www.ncbi.nlm.nih.gov/pubmed/33644734 http://dx.doi.org/10.1016/j.cjco.2020.09.024

Ejemplares similares

Left Ventricular Assist Device With a Left Atrial Inflow Cannula for Hypertrophic Cardiomyopathy
por: Kiamanesh, Omid, et al.
Publicado: (2020)

Myocardial recovery following durable left ventricular assist device support
por: Rao, Vivek, et al.
Publicado: (2021)

Aortic Thrombus Formation During Venoarterial Extracorporeal Membrane Oxygenation for Ventricular Septal Rupture
por: Kiamanesh, Omid, et al.
Publicado: (2020)

Prediction, prevention, and management of right ventricular failure after left ventricular assist device implantation: A comprehensive review
por: Rodenas-Alesina, Eduard, et al.
Publicado: (2022)

The changing landscape of left ventricular assist device care in the setting of a pandemic
por: Amadio, Jennifer M., et al.
Publicado: (2020)

Correction: Assessing the Use of Wrist-Worn Devices in Patients with Heart Failure: Feasibility Study
por: Moayedi, Yasbanoo, et al.
Publicado: (2018)

Assessing the Use of Wrist-Worn Devices in Patients With Heart Failure: Feasibility Study
por: Moayedi, Yasbanoo, et al.
Publicado: (2017)

Rapid Virtualization of a Heart Function Clinic in Response to the COVID-19 Pandemic
por: Linghorne, M., et al.
Publicado: (2021)

Predicting Survival After VA-ECMO for Refractory Cardiogenic Shock: Validating the SAVE Score
por: Amin, Faizan, et al.
Publicado: (2020)

Remote Mobile Outpatient Monitoring in Transplant (Reboot) 2.0: Protocol for a Randomized Controlled Trial
por: Murray, Kevin R, et al.
Publicado: (2021)

Clustered Emergency Room Visits Following an Acute Heart Failure Admission: A Population‐Based Study
por: Duero Posada, Juan G., et al.
Publicado: (2018)

Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy
por: Krämer, Johannes, et al.
Publicado: (2015)

Sparing the Prod: Providing an Alternative to Endomyocardial Biopsies With Noninvasive Surveillance After Heart Transplantation During COVID-19
por: Amadio, Jennifer M., et al.
Publicado: (2022)

Congenital heart disease confounding the diagnosis of arrhythmogenic right ventricular cardiomyopathy
por: Kiamanesh, Omid, et al.
Publicado: (2016)

Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis
por: Cheung, Edward, et al.
Publicado: (2021)

Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy
por: Meucci, Maria Chiara, et al.
Publicado: (2022)

Fabry Cardiomyopathy
por: Yoon, Jae Yong, et al.
Publicado: (2013)

Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation
por: Chien, Yueh, et al.
Publicado: (2016)

High Prevalence of Late-Onset Fabry Cardiomyopathy in a Cohort of 499 Non-Selective Patients with Left Ventricular Hypertrophy: The Asian Fabry Cardiomyopathy High-Risk Screening Study (ASIAN-FAME)
por: Fan, Yiting, et al.
Publicado: (2021)

ERT impact on left ventricular mass in Fabry disease
por: Ortiz, Alberto
Publicado: (2019)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy
por: Kim, Woo-Shik, et al.
Publicado: (2019)

Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy
por: Sadasivan, Chandu, et al.
Publicado: (2020)

A Case of Fabry Cardiomyopathy
por: Nah, Jong Chun, et al.
Publicado: (2009)

Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy
por: Graziani, Francesca, et al.
Publicado: (2020)

Left ventricular noncompaction cardiomyopathy
por: Hawatmeh, Amer, et al.
Publicado: (2017)

Arrhythmogenic left ventricular cardiomyopathy
por: Mirmomen, Seyedeh Mojdeh, et al.
Publicado: (2020)

Arrhythmogenic left ventricular cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2022)

Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis
por: Yousef, Zaheer, et al.
Publicado: (2013)

The E3 ligase Mule protects the heart against oxidative stress and mitochondrial dysfunction through Myc-dependent inactivation of Pgc-1α and Pink1
por: Dadson, Keith, et al.
Publicado: (2017)

Ethnic disparities in cardiac transplantation: opportunities to improve long-term outcomes in all cardiac transplant recipients
por: Kobulnik, Jeremy, et al.
Publicado: (2019)

Left ventricular function and survival in ischemic cardiomyopathy: Implications for surgical ventricular restoration
por: Adhyapak, Srilakshmi M., et al.
Publicado: (2021)

Screening for Fabry Disease in Left Ventricular Hypertrophy: Documentation of a Novel Mutation
por: Baptista, Ana, et al.
Publicado: (2015)

Does left ventricular function predict cardiac outcome in Anderson–Fabry disease?
por: Spinelli, Letizia, et al.
Publicado: (2020)

Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death
por: Hauck, Ludger, et al.
Publicado: (2017)

Left Ventricular Thrombus in Hypertrophic Cardiomyopathy
por: Hamada, Mareomi
Publicado: (2018)

Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction
por: Aleksova, Aneta, et al.
Publicado: (2019)

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
por: Kiamanesh, Omid, et al.
Publicado: (2015)

Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease
por: Pogoda, Christian, et al.
Publicado: (2023)

Poke Not Prod: First Canadian Experience Using Donor-Derived Cell Free DNA to Replace Endomyocardial Biopsy During COVID-19
por: Rodenas-Alesina, E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pl08pnq5ffj92cr06mhdqn8p9q